Main Article Content

Abstract

The healthcare sector is being impacted by information technology advancements in four key ways: first, a wide range of tasks that were previously performed manually can now be performed by computers; second, some tasks can be outsourced to other countries using affordable communications technology; third, longitudinal and societal healthcare data can now be analysed in acceptable amounts of time; and fourth, the best medical expertise can sometimes be made available. The healthcare industry will increasingly employ a portfolio approach made up of three closely coordinated components that are seamlessly integrated together: healthcare tasks performed by humans on-site; healthcare tasks performed by humans off-site, including tasks performed in other countries; and healthcare tasks performed by computers without direct human involvement. The three-pronged healthcare services paradigm is discussed in this essay along with relevant legal and intellectual property issues.


 

Keywords

Health Innovation IPR Legal Provisions Medicines

Article Details

How to Cite
Singh, Dr. Bhupinder. 2023. “INTELLECTUAL PROPERTY RIGHTS, INNOVATION AND HEALTHCARE: HARMONIZING THE LEGAL PROVISIONS FOR HEALTHCARE AND PHARMACEUTICAL INDUSTRY”. JIPRO: Journal of Intellectual Property, December, 58-67. https://doi.org/10.20885/jipro.vol6.iss2.art1.

References

  1. Gupta, A., Goyal, R. K., Joiner, K. A., & Saini, S. (2008). Outsourcing in the healthcare industry: Information technology, intellectual property, and allied aspects. Information Resources Management Journal (IRMJ), 21(1), 1-26.12-17.
  2. Dixit, T., Srivastava, S., Sahu, S., & Selvamurthy, W. (2018). Intellectual property evolution and innovation ecosystem as effective tools in strengthening Indian healthcare sector. Current Science, 1639-1649.
  3. Dwivedi, S., Anand, G., & Yadav, D. (2022). Intellectual property rights in healthcare: an overview. Biotechnology in Healthcare, Volume 1, 259-266.
  4. Williams, H. L. (2016). Intellectual property rights and innovation: Evidence from health care markets. Innovation Policy and the Economy, 16(1), 53-87.
  5. Pashkov, V. M., Golovanova, I. A., & Olefir, A. A. (2016). The impact of the legal regime of intellectual property protection in the pharmaceutical market. Wiadomosci Lekarskie (Warsaw, Poland: 1960), 69(3 pt 2), 582-586.
  6. Srinivas, S. (2008). intellectual Property rights, innovation and Healthcare: Unanswered questions in Theory and Policy. econômica, 10(2).
  7. Skiba, D. J. (1997). Intellectual property issues in the digital health care world. Nursing Administration Quarterly, 21(3), 11-20.
  8. Singh, H. B., Jha, A., & Keswani, C. (Eds.). (2016). Intellectual property issues in biotechnology. CABI.
  9. Amado, R., & Gewertz, N. M. (2004). Intellectual property and the pharmaceutical industry: A moral crossroads between health and property. Journal of business ethics, 55, 295-308.
  10. Deshpande, A. P., Ankola, A. V., Sankeshwari, R., Jalihal, S., Kabra, L., Bhat, D. V., & Choudhury, A. R. (2022). Assessment of knowledge and awareness regarding intellectual property rights among the health-care professionals in Belagavi city: A cross-sectional study. Journal of Education and Health Promotion, 11.
  11. Rao, S. L. (1994). The Indian health care industry: role of intellectual property rights. Intellectual Property Rights, (1), 165.